May 29, 2023
Insurance revenue increased by 14% to $10.98 Billion (2022: $9.61 Billion)
Insurance Service expenses increased by 11% to $8.79 Billion (2022: $7.92 Billion).
Insurance Service Result increased by 25% to $1.28 Billion (2022: $1.02 Billion).
The Net Insurance Finance Expense was $2.14 Billion. (2022: Net Insurance Finance Income of $3.15 Billion).
Unrealized Capital Gains were $1.32 Billion from a loss of $7.07 Billion the year before.
Net Interest Income increased by 1% to $5.51 Billion (2022: $5.44 Billion).
Net Insurance and Investment Result increased by 115% to $5.82 Billion (2022: $2.70 Billion)
Other Operating Expenses decreased by 4% to $6.26 Billion (2022: $6.50 Billion).
Profit before taxes increased by 259% to $3.07 Billion (2022: $855.82 Million)
Net Income for the period increased by 504% to $2.26 Billion (2022: Loss of $560.09 Million).
Net Profit attributable to Shareholders increased to $2.18 Billion (2022: Loss of $770.93 Million).
Earnings per share for the period was $0.56 relative to a Loss per share of $0.20 in 2022. The twelve month trailing EPS was $4.95. The number of shares used in the calculation was 3,905,634,916. SJ’s stock last traded on May 16, 2023 with a price of $48.99 and P/E of 9.90x.
Balance Sheet at a glance:
Total Assets decreased to $526.72 Billion compared to $528.53 Billion in the year prior. There was a 69% decreases in property plant and equipment to $6.37 Billion from the $20.47 Billion in the previous year.
Equity attributable to stockholders of the company as at March 31, 2023 increased by 8% to $83.53 Billion to $77.27 Billion in the previous year.
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
